Lizza Hendriks

6PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMolecular medicinePredictive and prognostic markersInstrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 30, 2026
Retrospective Evaluation of the Use of Continuous Palliative Sedation and Continuous Opioid Infusion in Hospitalized Patients in End-Of-Life Care.

J L Gulikers, J Hamers, M van der Zande

|Dec 09, 2024
Patient perspectives on treatment-related toxicities and therapeutic drug monitoring with tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer.

Judith Gulikers, Jeroen Bruinsma, Janna Schoenmaekers

|Jun 11, 2024
Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer.

Judith L Gulikers, Leila-Sophie Otten, Lizza E L Hendriks

|Jun 13, 2023
Comparison of characteristics of patients with lung cancer in U.K. primary care databases: Clinical Practice Research Datalink Aurum and GOLD.

J L Gulikers, A J van Veelen, J H M Driessen

|Jun 09, 2023
Durvalumab after chemoradiotherapy in patients with stage III non-small-cell lung cancer: real-world outcomes versus clinical trial results.

Marjon V Verschueren, Talitha Dijs, Judith L Gulikers

|Mar 20, 2023
Development and validation of an HPLC-MS/MS method to simultaneously quantify brigatinib, lorlatinib, pralsetinib and selpercatinib in human K2-EDTA plasma.

Judith L Gulikers, Ard J van Veelen, Elishia M J Sinkiewicz

Pageof 1

Frequent Collaborators

2 joint publications

Lizza El Hendriks

1 joint publications

M Theunissen

1 joint publications

M H J van den Beuken-van Everdingen

1 joint publications

Marjon V Verschueren